论文部分内容阅读
目的:观察并对比参松养心胶囊与胺碘酮治疗室性期前收缩的临床疗效。方法:38例室性期前收缩患者,随机分为两组,其中对照组在原发病常规治疗的基础上给予胺碘酮,治疗组在常规治疗的基础上应用参松养心胶囊,治疗结束后比较两组患者的心电图,临床症状及不良反应情况。结果:治疗组心电图总有效率为84.2%,对照组总有效率为89.5%,二者无统计学差异;同对照组相比,治疗组临床症状总有效率为89.5%,明显高于对照组(P<0.05);对照组不良反应发生率为26.3%,治疗组不良反应发生率为10.5%,两组比较有显著性差异(P<0.05)。结论:采用参松养心胶囊治疗室性期前收缩,治疗效果优于西药胺碘酮。
Objective: To observe and compare the clinical efficacy of Shensongyangxin Capsule and amiodarone in the treatment of ventricular contraction. Methods: Thirty-eight patients with premature ventricular contraction were randomly divided into two groups. The control group was given amiodarone on the basis of the routine treatment of the primary disease. The treatment group was given Shensong Yangxin Capsule on the basis of routine treatment. After the treatment Electrocardiogram, clinical symptoms and adverse reactions were compared between the two groups. Results: The total effective rate of electrocardiogram was 84.2% in the treatment group and 89.5% in the control group, with no significant difference between the two groups. The total effective rate of the clinical symptoms in the treatment group was 89.5%, which was significantly higher than that in the control group (P <0.05). The incidence of adverse reactions in the control group was 26.3%, and the incidence of adverse reactions in the treatment group was 10.5%. There was significant difference between the two groups (P <0.05). Conclusion: The Shensong Yangxin Capsule for the treatment of premature ventricular contractions, the treatment effect is superior to western medicine amiodarone.